Vascular Grafts Market Worth 3.80 Billion USD by 2022

Wednesday, January 24, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, January 24, 2018 /PRNewswire/ --

According to a new market research "Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

", published by MarketsandMarkets™, the market is expected to reach USD 3.80 Billion by 2022 from USD 2.67 Billion in 2017, at a CAGR of 7.3%.



Browse 75 market data Tables and 31 Figures spread through 112 Pages and in-depth TOC on "Vascular Graft Market"

Early buyers will receive 10% customization on this report 

Factors driving the growth of this market include in the aging population and the associated increase in the prevalence of aneurysms, rise in end-stage renal disorders, and increasing adoption of minimally invasive surgical procedures.

Polyester grafts segment is estimated to account for the largest market share in 2017 

By raw material, the Vascular Grafts Market is segmented into ePTFE grafts, polyester grafts, polyurethane grafts, and biosynthetic grafts. Polyester grafts are likely to dominate this market in 2017. The growth of this segment is primarily driven by various factors such as high demand for polyester material-based grafts owing to its various benefits such as a long lifespan and high patency and porousness.

Inquiry Before Buying @

The endovascular aneurysm repair segment is expected to dominate the market in 2017 

By indications, the Vascular Grafts Market is categorized into endovascular aneurysm repair or EVAR (including abdominal aortic aneurysms repair and thoracic aneurysm repair), hemodialysis access, and peripheral vascular aneurysm. The EVAR segment is estimated to account for the largest market share owing to the high demand for endovascular aneurysms repair procedures. The EVAR segment is further bifurcated into abdominal aneurysm repair and thoracic aneurysms repair. The abdominal aneurysm repair subsegment will occupy the largest market as a majority of aneurysms occur in the abdominal region.

Hospitals are estimated to command the largest share of the market during the forecast period 

By end user, the Vascular Grafts Market is bifurcated into hospitals and ambulatory surgical centers (ASCs). The high growth of this segment is attributed to factors such as the rising number of minimally invasive surgical procedures in hospitals & cardiac centers and the favorable reimbursement scenario for hospital procedures in most developed countries.

Download PDF Brochure@

North America is estimated to command the largest share of the market 

Based on region, the Vascular Grafts Market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is expected to dominate this market in 2017. Factors such as increasing healthcare expenditure and research and development in the field of vascular grafts are propelling the growth of the Vascular Grafts Market in this region.

Key players operating in Vascular Grafts Market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).

Browse Related Reports 

Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021

Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Rohan MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email:

Connect with us on LinkedIn @

SOURCE MarketsandMarkets

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store